IP Library Assignment 062689/0822
Patent Assignment
Reel/Frame 062689/0822

Assignment of Assignor's Interest

Recorded: 2023-02-14 Pages: 6
Assignors
FREEMAN, GORDON J.
Executed: 2020-01-29
BU, XIA
Executed: 2020-01-30
Assignee
DANA-FARBER CANCER INSTITUTE, INC.
450 BROOKLINE AVENUE, BOSTON, MASSACHUSETTS, 02215-5450
Covered Property (1)
Method of Assessing the Efficacy of a Test Agent for Modulating Programmed Death 1 (Pd-1) Signaling by Using Anti-Phosphotyrosinylated Pd-1 Monoclonal Antibodies
Application: 17/934,441 →
Publication: US 2023/0331847
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 14, 2023
From: BOUSSIOTIS, VASSILIKI A.; PATSOUKIS, NIKOLAOS; WEAVER, JESSICA; STRAUSS, LAURA
To: BETH ISRAEL DEACONESS MEDICAL CENTER
Reel/Frame 062689/0839 →
Assignment of Assignor's Interest Feb 14, 2023
From: JUNEJA, VIKRAM R.; SHARPE, ARLENE H.
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 062689/0847 →
Confirmatory License Jan 29, 2024
From: DANA-FARBER CANCER INST
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 066377/0563 →